Cargando…
Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644701/ https://www.ncbi.nlm.nih.gov/pubmed/33011938 http://dx.doi.org/10.1007/s13300-020-00842-w |
| _version_ | 1783606508558221312 |
|---|---|
| author | Guja, Cristian Frías, Juan P. Suchower, Lisa Hardy, Elise Marr, Galina Sjöström, C. David Jabbour, Serge A. |
| author_facet | Guja, Cristian Frías, Juan P. Suchower, Lisa Hardy, Elise Marr, Galina Sjöström, C. David Jabbour, Serge A. |
| author_sort | Guja, Cristian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7644701 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76447012020-11-10 Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease Guja, Cristian Frías, Juan P. Suchower, Lisa Hardy, Elise Marr, Galina Sjöström, C. David Jabbour, Serge A. Diabetes Ther Correction Springer Healthcare 2020-10-04 2020-12 /pmc/articles/PMC7644701/ /pubmed/33011938 http://dx.doi.org/10.1007/s13300-020-00842-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Correction Guja, Cristian Frías, Juan P. Suchower, Lisa Hardy, Elise Marr, Galina Sjöström, C. David Jabbour, Serge A. Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease |
| title | Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease |
| title_full | Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease |
| title_fullStr | Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease |
| title_full_unstemmed | Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease |
| title_short | Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease |
| title_sort | correction to: safety and efficacy of exenatide once weekly in participants with type 2 diabetes and stage 2/3 chronic kidney disease |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644701/ https://www.ncbi.nlm.nih.gov/pubmed/33011938 http://dx.doi.org/10.1007/s13300-020-00842-w |
| work_keys_str_mv | AT gujacristian correctiontosafetyandefficacyofexenatideonceweeklyinparticipantswithtype2diabetesandstage23chronickidneydisease AT friasjuanp correctiontosafetyandefficacyofexenatideonceweeklyinparticipantswithtype2diabetesandstage23chronickidneydisease AT suchowerlisa correctiontosafetyandefficacyofexenatideonceweeklyinparticipantswithtype2diabetesandstage23chronickidneydisease AT hardyelise correctiontosafetyandefficacyofexenatideonceweeklyinparticipantswithtype2diabetesandstage23chronickidneydisease AT marrgalina correctiontosafetyandefficacyofexenatideonceweeklyinparticipantswithtype2diabetesandstage23chronickidneydisease AT sjostromcdavid correctiontosafetyandefficacyofexenatideonceweeklyinparticipantswithtype2diabetesandstage23chronickidneydisease AT jabboursergea correctiontosafetyandefficacyofexenatideonceweeklyinparticipantswithtype2diabetesandstage23chronickidneydisease |